EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA) (2021)
FDG-PET/CT External Beam Radiotherapy Treatment Planning in Uterine Cervical Cancer 2020
EANM / SNMMI Practice Guideline for [18F]FDG PET/CT External Beam Radiotherapy Treatment Planning in Uterine Cervical Cancer (2020)
The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers (2014)
GYNECOLOGICAL CANCER
Joint EANM/SNMMI/IHPBA procedure guideline for [99mTc]Tc-mebrofenin hepatobiliary scintigraphy SPECT/CT in the quantitative assessment of the future liver remnant function (2023)
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds (2022)
LIVER MALIGNANCIES
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT) (2023)
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0 (2023)
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET (2021)
Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline - Endorsed by SNMMI 2020
[18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging—version 1.0 (2019)
The EAU – EANM – ESTRO – ESUR – SIOG Guidelines on Prostate Cancer (2019)
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0 (2017)
PROSTATE CANCER
SNMMI Procedure Standard/EANM Practice Guideline for SSTR Receptor PET: Imaging Neuroendocrine Tumors (2023)
Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA (2017) AND Erratum
EANM Practice Guideline/SNMMI Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma (2019)
EANM 131I/123I- Metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging 2010– SNMMI Endorsement
NEUROENDOCRINE TUMORS
SNMMI Procedure Standard/EANM Practice Guideline for Molecular Breast Imaging with Dedicated γ-Cameras (2022)
EANM/SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer (2013)
Breast scintigraphy with breast-specific gamma cameras 1.0 (2010)
SNM Breast Scintigraphy 2.0 2004
BREAST CANCER
Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0 (2022)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 (2014)
Integration of FDG-PET/CT into external beam radiation therapy planning (2012)
PET/CT
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer (2022)
Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0. (2022)
LUNG CANCER
EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma (2015)
in cooperation with the European Society of Surgical Oncology (ESSO) and the European Organisation for Research and Treatment of Cancer (EORTC) Melanoma Group. endorsed by the Society of Nuclear Medicine and Molecular Imaging (SNMMI)